These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 20236938)

  • 1. Crystal structure of thrombin bound to the uncleaved extracellular fragment of PAR1.
    Gandhi PS; Chen Z; Di Cera E
    J Biol Chem; 2010 May; 285(20):15393-15398. PubMed ID: 20236938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural identification of the pathway of long-range communication in an allosteric enzyme.
    Gandhi PS; Chen Z; Mathews FS; Di Cera E
    Proc Natl Acad Sci U S A; 2008 Feb; 105(6):1832-7. PubMed ID: 18250335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of protease exosite-interacting peptides that enhance substrate cleavage kinetics.
    Jabaiah AM; Getz JA; Witkowski WA; Hardy JA; Daugherty PS
    Biol Chem; 2012 Sep; 393(9):933-41. PubMed ID: 22944693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin Exosite Maturation and Ligand Binding at ABE II Help Stabilize PAR-Binding Competent Conformation at ABE I.
    Billur R; Sabo TM; Maurer MC
    Biochemistry; 2019 Feb; 58(8):1048-1060. PubMed ID: 30672691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease-activated receptor-4 uses dual prolines and an anionic retention motif for thrombin recognition and cleavage.
    Jacques SL; Kuliopulos A
    Biochem J; 2003 Dec; 376(Pt 3):733-40. PubMed ID: 13678420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protease-activated receptor-1 cleaved at R46 mediates cytoprotective effects.
    Schuepbach RA; Madon J; Ender M; Galli P; Riewald M
    J Thromb Haemost; 2012 Aug; 10(8):1675-84. PubMed ID: 22712885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GpIbα interacts exclusively with exosite II of thrombin.
    Lechtenberg BC; Freund SM; Huntington JA
    J Mol Biol; 2014 Feb; 426(4):881-93. PubMed ID: 24316004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mapping of thrombin-receptor interactions.
    Ayala YM; Cantwell AM; Rose T; Bush LA; Arosio D; Di Cera E
    Proteins; 2001 Nov; 45(2):107-16. PubMed ID: 11562940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin.
    Vijayalakshmi J; Padmanabhan KP; Mann KG; Tulinsky A
    Protein Sci; 1994 Dec; 3(12):2254-71. PubMed ID: 7756983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for thrombin activation of a protease-activated receptor: inhibition of intramolecular liganding.
    Seeley S; Covic L; Jacques SL; Sudmeier J; Baleja JD; Kuliopulos A
    Chem Biol; 2003 Nov; 10(11):1033-41. PubMed ID: 14652070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hirudin binding reveals key determinants of thrombin allostery.
    Mengwasser KE; Bush LA; Shih P; Cantwell AM; Di Cera E
    J Biol Chem; 2005 Jul; 280(29):26997-7003. PubMed ID: 15923186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-linked glycosylation of protease-activated receptor-1 second extracellular loop: a critical determinant for ligand-induced receptor activation and internalization.
    Soto AG; Trejo J
    J Biol Chem; 2010 Jun; 285(24):18781-93. PubMed ID: 20368337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of thrombin with PAR1 and PAR4 at the thrombin cleavage site.
    Nieman MT; Schmaier AH
    Biochemistry; 2007 Jul; 46(29):8603-10. PubMed ID: 17595115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-resolution crystal structure of human protease-activated receptor 1.
    Zhang C; Srinivasan Y; Arlow DH; Fung JJ; Palmer D; Zheng Y; Green HF; Pandey A; Dror RO; Shaw DE; Weis WI; Coughlin SR; Kobilka BK
    Nature; 2012 Dec; 492(7429):387-92. PubMed ID: 23222541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease-activated receptor 4 uses anionic residues to interact with alpha-thrombin in the absence or presence of protease-activated receptor 1.
    Nieman MT
    Biochemistry; 2008 Dec; 47(50):13279-86. PubMed ID: 19053259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of thrombin activity with PAR 1-based fluorogenic peptides.
    Vieira SM; dos Reis FG; Geraldo R; Dutra DL; Juliano L; Julianod MA; Mignaco JA; Zingali RB
    Protein Pept Lett; 2013 Oct; 20(10):1129-35. PubMed ID: 23688151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes.
    Mathews II; Padmanabhan KP; Ganesh V; Tulinsky A; Ishii M; Chen J; Turck CW; Coughlin SR; Fenton JW
    Biochemistry; 1994 Mar; 33(11):3266-79. PubMed ID: 8136362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis of thrombin-protease-activated receptor interactions.
    Gandhi PS; Chen Z; Appelbaum E; Zapata F; Di Cera E
    IUBMB Life; 2011 Jun; 63(6):375-82. PubMed ID: 21698746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of exosite ligands to human thrombin. Re-evaluation of allosteric linkage between thrombin exosites I and II.
    Verhamme IM; Olson ST; Tollefsen DM; Bock PE
    J Biol Chem; 2002 Mar; 277(9):6788-98. PubMed ID: 11724802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dual role of thrombin's anion-binding exosite-I in the recognition and cleavage of the protease-activated receptor 1.
    Myles T; Le Bonniec BF; Stone SR
    Eur J Biochem; 2001 Jan; 268(1):70-7. PubMed ID: 11121104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.